{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:49:57Z","timestamp":1789757397755,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1269-1","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T09:23:55Z","timestamp":1490001835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8241-4869","authenticated-orcid":false,"given":"Stephanie","family":"van den Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Villiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"\u00d8stensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"F\u00f6rger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"issue":"3","key":"1269_CR1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2013.03.004","volume":"13","author":"M Ostensen","year":"2013","unstructured":"Ostensen M, F\u00f6rger F. How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol. 2013;13(3):470\u20135.","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"1269_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G","volume":"42","author":"JH Barrett","year":"1999","unstructured":"Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999;42(6):1219\u201327.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1269_CR3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","volume":"59","author":"YA Man de","year":"2008","unstructured":"de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1269_CR4","first-page":"120","volume":"25","author":"M Ostensen","year":"1998","unstructured":"Ostensen M, Ostensen H. Ankylosing spondylitis\u2014the female aspect. J Rheumatol. 1998;25(1):120\u20134.","journal-title":"J Rheumatol"},{"issue":"10","key":"1269_CR5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/ard.2003.016881","volume":"63","author":"M Ostensen","year":"2004","unstructured":"Ostensen M, Fuhrer L, Mathieu R, Seitz M, Villiger PM. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis. 2004;63(10):1212\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1269_CR6","first-page":"w13644","volume":"142","author":"F F\u00f6rger","year":"2012","unstructured":"F\u00f6rger F, Vallbracht I, Helmke K, Villiger PM, Ostensen M. Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly. 2012;142:w13644.","journal-title":"Swiss Med Wkly."},{"issue":"2","key":"1269_CR7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/ard.2008.104331","volume":"69","author":"YA Man de","year":"2010","unstructured":"de Man YA, Bakker-Jonges LE, Goorbergh CM, Tillemans SP, Hooijkaas H, Hazes JM, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis. 2010;69(2):420\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1269_CR8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","volume":"70","author":"SM Verstappen","year":"2011","unstructured":"Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL, BSRBR Control Centre Consortium, BSR Biologics Register. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011;70(5):823\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1269_CR9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34(10):1218\u201327.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1269_CR10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1269_CR11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/art.22773","volume":"57","author":"YA Man de","year":"2007","unstructured":"de Man YA, Hazes JM, van de Geijn FE, Krommenhoek C, Dolhain RJ. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57(5):716\u201322.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1269_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.2006.061002","volume":"66","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66(2):143\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1269_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1269_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70(1):47\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"6-7","key":"1269_CR15","doi-asserted-by":"crossref","first-page":"A437","DOI":"10.1016\/j.autrev.2011.11.013","volume":"11","author":"M \u00d8stensen","year":"2012","unstructured":"\u00d8stensen M, Villiger PM, F\u00f6rger F. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev. 2012;11(6-7):A437\u201346.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"1269_CR16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/rheumatology\/kew033","volume":"55","author":"V Navarro-Compan","year":"2016","unstructured":"Navarro-Compan V, Plasencia-Rodriguez C, de Miguel E, Balsa A, Martin-Mola E, Seoane-Mato D, et al. Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review. Rheumatology. 2016;55(7):1188\u201394.","journal-title":"Rheumatology"},{"issue":"6","key":"1269_CR17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2014-206435","volume":"74","author":"A Kavanaugh","year":"2015","unstructured":"Kavanaugh A, Lee SJ, Curtis JR, Greenberg JD, Kremer JM, Soto L, et al. Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry. Ann Rheum Dis. 2015;74(6):1150\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1269_CR18","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3899\/jrheum.151179","volume":"43","author":"P Wiland","year":"2016","unstructured":"Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, et al. The effect of reduced or withdrawn etanercept-methotrexate therapy on patient-reported outcomes in patients with early rheumatoid arthritis. J Rheumatol. 2016;43(7):1268\u201377.","journal-title":"J Rheumatol"},{"issue":"3","key":"1269_CR19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cgh.2012.10.024","volume":"11","author":"Z Zelinkova","year":"2013","unstructured":"Zelinkova Z, van der Ent C, Bruin KF, van Baalen O, Vermeulen HG, Smalbraak HJ, et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol. 2013;11(3):318\u201321.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"1269_CR20","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/ard.2004.033019","volume":"64","author":"F F\u00f6rger","year":"2005","unstructured":"F\u00f6rger F, Ostensen M, Schumacher A, Villiger PM. Impact of pregnancy on health related quality of life evaluated prospectively in pregnant women with rheumatic diseases by the SF-36 Health Survey. Ann Rheum Dis. 2005;64(10):1494\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1269_CR21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795\u2013810.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1269_CR22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al. 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896\u2013904.","journal-title":"Ann Rheum Dis"},{"key":"1269_CR23","doi-asserted-by":"crossref","unstructured":"van der Maas A, Lie E, Christensen R, Choy E, de Man YA, van Riel P, Woodworth T, den Broeder AA. Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study. Ann Rheum Dis. 2013;72(11):1800\u20135.","DOI":"10.1136\/annrheumdis-2012-202281"},{"key":"1269_CR24","doi-asserted-by":"crossref","unstructured":"Gossec L, Portier A, Landewe R, Etcheto A, Navarro-Compan V, Kroon F, van der Heijde D, Dougados M. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative. Ann Rheum Dis. 2016;75(6):991\u20136.","DOI":"10.1136\/annrheumdis-2015-208593"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:01:50Z","timestamp":1498381310000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1269-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1269-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]},"article-number":"64"}}